Lombard Medical Receives Australian Therapeutic Goods Administration Approval for the Aorfix Endovascular Stent Graft for the Treatment of Abdominal Aortic Aneurysms

Lombard Medical, Inc. announced that the Australian Therapeutic Goods Administration approved the Aorfix™ Endovascular Stent Graft for inclusion on the Australian Register of Therapeutic Goods. The Therapeutic Goods Administration approved the use of Aorfix for the treatment of abdominal aortic aneurysms with aortic neck angulations up to 90 degrees.